CGM Use in Children With Type 2 Diabetes
Completed · Not applicable
Conditions studied: Type 2 Diabetes, Hyperglycemia Due to Type 2 Diabetes Mellitus
In brief
The purpose of this prospective study is to determine if trial use of a Dexcom G6 CGM system for a 10 day wear period in pediatric Type 2 diabetes patients improves short term time in range glucose control and 3-6 month glycemic control.
Key facts
- Study ID
- NCT04721158
- Run by
- Johns Hopkins University
- People needed
- 41
- Starts
- 2021-01-17
- Expected to finish
- 2022-07-28
- Last updated by the study team
- 2023-09-15
Who can join
Age: 5 and older, up to 21. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Type 2 diabetes, diabetes duration >3 months
You may not qualify if…
- Prior use of CGM
Where it is running
- Johns Hopkins Pediatric Diabetes Center — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.